Status:
COMPLETED
Photographic Library of Moderate to Severe Psoriasis Subjects Treated With Infliximab (Study P05047)
Lead Sponsor:
Merck Sharp & Dohme LLC
Conditions:
Psoriasis
Eligibility:
All Genders
18+ years
Brief Summary
This is a national, multi-center, observational, prospective photographic atlas study in subjects who are treated with infliximab for moderate-to-severe psoriasis in daily clinic according to local co...
Detailed Description
Subjects will enter this study using a non-probability sampling method.
Eligibility Criteria
Inclusion
- Male or female, age \>=18 with moderate-to-severe psoriasis.
- Patient for whom the physician has decided to initiate psoriasis treatment with infliximab in accordance with the terms of the European labeling.
- Patient must demonstrate his/her willingness to participate in the observational study by signing a written consent.
Exclusion
- Patient unable to understand and answer a self administered questionnaire.
- No specific non-inclusion criteria will be applied to eligible patients.
- Contradiction and/or Precaution listed in the Summary of Product Characteristics.
Key Trial Info
Start Date :
September 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2010
Estimated Enrollment :
133 Patients enrolled
Trial Details
Trial ID
NCT00749398
Start Date
September 1 2007
End Date
September 1 2010
Last Update
July 28 2015
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.